R.H.N. van Schaik

A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach

Franc Andreu, Helena Colom, Laure Elens et al. · Clinical Pharmacokinetics · 2017 · 92 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662

Meta H.M. Diekstra, Heinz‐Josef Klümpen, Martijn P. Lolkema et al. · Clinical Pharmacology & Therapeutics · 2014 · 76 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +17

Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe

Mirjam de With, A. Sadlon, Erika Cecchin et al. · ESMO Open · 2023 · 67 citations · Full text

Medicine, Pharmacology, Medical Genetics +14

Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms.

Annemiek van der Padt, R.H.N. van Schaik, Pieter Sonneveld · PubMed · 2006 · 59 citations · Full text

Medicine, Genetics, Pharmacology +16

Differential regulation of inhibin/activin α- and βA-subunit and follistatin mRNAs by cyclic AMP and phorbol ester in cultured human granulosa-luteal cells

Timo Tuuri, M Erämaa, R.H.N. van Schaik et al. · Molecular and Cellular Endocrinology · 1996 · 39 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9